AKL003

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameAKL003
Drug Alias NameKlotho-based therapies (Klothea Bio)alpha Klotho mRNA formulated in lipid nanoparticles (Klothea Bio)AKL-003aKLmRNA
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionKlotho modulators
TargetsKlotho
Therapy Area/IndicationsHealthy AgingObesityAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHonduras
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKlothea Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesKlothea Bio Inc
Inactive CompaniesN/A
Active IndicationsHealthy AgingObesityAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A